Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01758731
Title Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

hypopharynx cancer

oropharynx cancer

laryngeal squamous cell carcinoma

Therapies

Cetuximab + Olaparib

Age Groups: adult
Covered Countries USA


No variant requirements are available.